Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision indicator has been updated from **Revision v3.5.2** to **Revision v3.5.3**. A glossary/term display for **“Idiopathic Pulmonary Fibrosis”** is present, without altering the study’s substantive details.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the keyword 'Interstitial lung disease 2' from the page metadata/keywords.SummaryDifference0.1%

- Check56 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedPulmonary fibrosis was added to the Keywords/MeSH terms to better reflect the studied condition and improve indexing.SummaryDifference0.1%

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.